Assessment of Food and Drug Administration– and European Medicines Agency–Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

समान संसाधन

• Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs
  द्वारा: Saluja, Ronak, और अन्य
  प्रकाशित: (2021)
• Assessment of Whether the American Society of Clinical Oncology’s Value Framework and the European Society for Medical Oncology’s Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: An Analysis of Randomized Clinical Trials
  द्वारा: Saluja, Ronak, और अन्य
  प्रकाशित: (2019)
• Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits
  द्वारा: Ambica Parmar, और अन्य
  प्रकाशित: (2020-01-01)
• Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits
  द्वारा: Parmar, Ambica, और अन्य
  प्रकाशित: (2019)
• EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
  प्रकाशित: (2015-09-01)